Electroacupuncture to treat with Overactive Bladder in Postmenopausal Women: study protocol for a multicenter, randomized, controlled, parallel clinical trial

Eun-Young Nam, Ju-Yeon Park, Junyoung Jo, Seung-Hyun Jung, Chi-Yeon Lim, Dong-Il Kim, Eun-Young Nam, Ju-Yeon Park, Junyoung Jo, Seung-Hyun Jung, Chi-Yeon Lim, Dong-Il Kim

Abstract

Background: Electroacupuncture has been used for treatment in patients with overactive bladder. This study was conducted to evaluate the efficacy and safety of electroacupuncture for treating overactive bladder of postmenopausal women.

Methods/design: This is a multicenter, randomized controlled, parallel clinical trial. Two hundred ninety participants with overactive bladder syndrome will be recruited from Dongguk University Bundang Oriental Hospital and Cheonan Korean Medicine Hospital of Daejeon University and randomly allocated into one of two groups in a 1:1 ratio. One group will receive electroacupuncture (EA) and the other acupuncture (AC). The allocation will be concealed from both participants and assessors. The study period will be about 10 weeks, including 6 weeks of electroacupuncture or acupuncture treatment and a four week follow-up period. Both EA group and AT group will undergo acupuncture at 7 fixed points, and the EA group will undergo electronic stimulation at 6 points. The primary outcome will be the average number of micturitions per 24 h based on a 3-day bladder diary. The secondary outcome will comprise the 3-day bladder diary, the overactive bladder symptom score and the results of the King's health questionnaire.

Discussion: The results of this trial will provide information regarding the efficacy and safety of electroacupuncture for treating overactive bladder in postmenopausal women.

Trial registration: ClinicalTrials.gov, NCT03260907 . Registered on 24 August 2017.

Keywords: Electroacupuncture; Menopause; Overactive bladder; Postmenopausal overactive bladder.

Conflict of interest statement

Ethics approval and consent to participate

The study protocol was approved by the Institutional Review Boards (IRBs) of Dongguk University Bundang Oriental Hospital (2017–0008). The study procedures will follow the protocols approved by the IRB, and only patients who provide written consent will be included.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Flowchart of the study process

References

    1. Temml C, Heidler S, Ponholzer A, Madersbacher S. Prevalence of the overactive bladder syndrome by applying the International Continence Society definition. Eur Urol. 2005;48:622–627. doi: 10.1016/j.eururo.2005.04.026.
    1. Coyne KS, Sexton CC, Kopp ZS, Ebel-Bitoun C, Milsom I, Chapple C. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int. 2011;108:1459–1471. doi: 10.1111/j.1464-410X.2010.10013.x.
    1. Haylen B, de Ridder D, Freeman R, Swift S, Berghmans B, Lee J, Monga A, Petri E, Rizk D, Sand P. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. J Assoc Chart Physiother Womens Health. 2012;110:33.
    1. Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster HE, Scarpero HM, Tessier CD. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188:2455–2463. doi: 10.1016/j.juro.2012.09.079.
    1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37–49. doi: 10.1016/S0090-4295(02)02243-4.
    1. Sang JH, Park HM. Survey on the prevalence of overactive bladder in healthy Korean postmenopausal women. J Kor Soc Menopause. 2012;18:60–66. doi: 10.6118/jksm.2012.18.1.60.
    1. Milsom I, Abrams P, Cardozo L, Roberts R, Thüroff J, Wein A. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87:760–766. doi: 10.1046/j.1464-410x.2001.02228.x.
    1. Kim Y-J, Kim M-C, Lee C-H, Kim J-U, Yook T-H. The effect of needle-embedding therapy and pharmacopuncture therapy on patients with urinary incontinence. J Acupunct Meridian Stud. 2011;4:220–224. doi: 10.1016/j.jams.2011.10.012.
    1. Choi M-S, Kim D-I. A Study on Korean Medical Clinical Management of Female Overactive Bladder. J Korean Obstet Gynecol. 2014;27:83–102. doi: 10.15204/jkobgy.2014.27.2.083.
    1. Kim D, Choi C, Ahn I, Ryu I, Choi M, Lee Y, Lee MS. Efficacy and safety of Baweidihuang-wan in women with overactive bladder: a randomized, double blind, placebo controlled trial. Int J Clin Exp Med. 2014;7:2744.
    1. Han J-S. Acupuncture analgesia: areas of consensus and controversy. Pain. 2011;152:S41–S48. doi: 10.1016/j.pain.2010.10.012.
    1. Burnstock G. Acupuncture: a novel hypothesis for the involvement of purinergic signalling. Med Hypotheses. 2009;73:470–472. doi: 10.1016/j.mehy.2009.05.031.
    1. Stewart F, Berghmans B, Bø K, Glazener CM. Electrical stimulation with non-implanted devices for stress urinary incontinence in women. Cochrane Database Syst Rev 2016;10:CD012390.
    1. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18. doi: 10.1186/1741-7015-8-18.
    1. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, Moher D. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med. 2010;3:140–155. doi: 10.1111/j.1756-5391.2010.01086.x.
    1. Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O. Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score. Urology. 2006;68:318–323. doi: 10.1016/j.urology.2006.02.042.
    1. Yamaguchi O, Nishizawa O, Takeda M, Yokoyama O, Homma Y, Kakizaki H, Obara K, Gotoh M, Igawa Y, Seki N. Clinical guidelines for overactive bladder. Int J Urol. 2009;16:126–142. doi: 10.1111/j.1442-2042.2008.02177.x.
    1. Kelleher CJ, Cardozo LD, Toozs-Hobson PM. Quality of life and urinary incontinence. Curr Opin Obstet Gynecol. 1995;7:404–408. doi: 10.1097/00001703-199510000-00016.
    1. Kelleher C, Cardozo L, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. BJOG. 1997;104:1374–1379. doi: 10.1111/j.1471-0528.1997.tb11006.x.
    1. Reese PR, Pleil AM, Okano GJ, Kelleher CJ. Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder. Qual Life Res. 2003;12:427–442. doi: 10.1023/A:1023422208910.
    1. Carmona MVO, Molleja ÁMG, Ríos IL, Torronteras AR, Tamajón VMC, Obrero IG. Neuroestimulación percutánea del nervio tibial posterior frente a neuroestimulación de B 6 (Sanyinjiao) en incontinencia urinaria de urgencia. Revista Internacional de Acupuntura. 2013;7:124–130. doi: 10.1016/S1887-8369(13)70102-9.
    1. van BALKEN MR, Vandoninck V, Gisolf KW, Vergunst H, Kiemeney LA, Debruyne FM, Bemelmans BL. Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. J Urol. 2001;166:914–918. doi: 10.1016/S0022-5347(05)65863-6.
    1. Klingler H, Pycha A, Schmidbauer J, Marberger M. Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology. 2000;56:766–771. doi: 10.1016/S0090-4295(00)00727-5.
    1. Peters KM, MacDiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, Siegel SW, Tate SB, Jarnagin BK, Rosenblatt PL. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009;182:1055–1061. doi: 10.1016/j.juro.2009.05.045.
    1. MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC, Siegel SW, Tate SB, Feagins BA. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol. 2010;183:234–240. doi: 10.1016/j.juro.2009.08.160.
    1. Vandoninck V, van Balken MR, Agró EF, Petta F, Caltagirone C, Heesakkers JP, Kiemeney LA, Debruyne FM, Bemelmans BL. Posterior tibial nerve stimulation in the treatment of urge incontinence. Neurourol Urodyn. 2003;22:17–23. doi: 10.1002/nau.10036.
    1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002;187:116–126. doi: 10.1067/mob.2002.125704.
    1. Abrams P, Blaivas JG, Stanton SL, Andersen JT. The standardisation of terminology of lower urinary tract function. The International Continence Society Conunittee on Standardisation of Terminology. Scand J Urol Nephrol Suppl. 1988;114:5–19..
    1. Philp T, Shah P, Worth P. Acupuncture in the treatment of bladder instability. BJU Int. 1988;61:490–493. doi: 10.1111/j.1464-410X.1988.tb05086.x.
    1. Paik SH, Han SR, Kwon OJ, Ahn YM, Lee BC, Ahn SY. Acupuncture for the treatment of urinary incontinence: A review of randomized controlled trials. Exp Ther Med. 2013;6:773–780. doi: 10.3892/etm.2013.1210.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere